ClinConnect ClinConnect Logo
Search / Trial NCT06870045

Dynamic Gait Index As a Functional Gait Assessment Measure in Children with JIA

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Mar 5, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Juvenile Idiopathic Arthritis Gait Dynamic Gait Index Childhood Rheumatic Diseases

ClinConnect Summary

This clinical trial is studying a tool called the Dynamic Gait Index (DGI) to see if it can help assess walking difficulties in children with Juvenile Idiopathic Arthritis (JIA). JIA is a condition that causes pain and swelling in the joints, which can make it hard for kids to walk properly and enjoy their daily activities. The DGI tests various walking skills, such as walking straight, changing speeds, and navigating around obstacles. Researchers want to find out if this tool is effective for children aged 8 to 16 who have JIA, as there aren’t many ways to measure walking difficulties in these kids right now.

To participate in this study, children must be diagnosed with JIA and have issues with one knee that affects their walking. They should be between 8 and 16 years old and able to follow simple instructions. There is also a control group made up of children without any health issues that might affect walking. Participants can expect to take part in walking tests using the DGI, which will help researchers understand if this tool can accurately assess walking in children with JIA, potentially leading to better care and support for these patients in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Study Group;
  • Having a JIA diagnosis according to ILAR criteria between the ages of 8-16,
  • Having unilateral knee joint involvement that will affect walking
  • Being compatible, volunteer and cooperative in the study Control Group;
  • 1. Not having any neurological or orthopedic diagnosis
  • 2. Being between the ages of 8-16
  • 3. Being at a mental level that can understand the commands of the person performing the evaluation
  • Exclusion Criteria:
  • Study Group;
  • Having an additional neurological or orthopedic diagnosis accompanying JIA and affecting treatment results,
  • Having lower extremity asymmetry or active lower extremity involvement other than the knee joint that will affect walking.
  • Control Group;
  • -Having any health problem that may affect the study

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Istanbul, Buyukcekmece, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported